Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Why Food Companies Want You to Make Your Own Meal

The traditional home-cooked meal has forever been changed thanks to the popularity of meal kits. Nine percent of Americans, or 10.5 million households, have purchased a meal kit in the previous six months. Meal kits provide pre-measured ingredients and step-by-step recipes for people to make at-home meals that are restaurant quality but without the price…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

The traditional home-cooked meal has forever been changed thanks to the popularity of meal kits. Nine percent of Americans, or 10.5 million households, have purchased a meal kit in the previous six months.

Meal kits provide pre-measured ingredients and step-by-step recipes for people to make at-home meals that are restaurant quality but without the price tag. Customers get a quick and healthy meal that is convenient and relatively easy to cook. Services such as Blue Apron, Plated and Hello Fresh provide meals that even the most novice of cooks can complete.

What might be more attractive to consumers however, is that it eliminates the need to go to the grocery store.

However, the market has become crowded due to the concept’s growing popularity. More than 150 meal-kit companies are operating in the U.S. today. Companies are creating all types of kits to suit every customer preference – vegetarian, plant-based, vegan, organic, and gluten-free. The list is endless. New services continue to pop up, often trying to differentiate themselves by focusing on one food type. GreenBlender, for example, focuses entirely on smoothies while Daily Harvest offers meals and snacks that are blended, then eaten directly from the container.

Meal kit companies face a major problem in retaining customers. Consumers quickly move on to try the next food craze or try another service with a better deal. One way companies are trying to combat this is by partnering with celebrities to create exclusive recipes. Chrissy Teigen partnered with Blue Apron to create six dining options. Olympic gymnast, Aly Raisman, has teamed up with Purple Carrot to help the company promote an active and healthy lifestyle.

There is also an increase in alliances between meal kit providers and retailers. In some cases, grocery stores are creating their own meal kits. Kroger is testing out meal kit stations that are designed to allow customers to personalize their dinner. Their “Easy for You!” program allows shoppers to select from a variety of frozen entrees and side dishes to package and take home to cook. Blue Apron is piloting a partnership with Costco to offer the kits in-store and Albertsons purchased Plated in mid-2017.

Restaurants are also catching on to the meal kit trend. Chick-fil-A is testing its own meal kit with five recipe options that are straightforward and family-friend. Each kit can be prepared in 30 minutes and serves two people. Unlike other meal kit services, Chick-fil-A kits don’t require shoppers to pre-plan and commit up to a week before through a subscription.

Overall, the convenience of meal kits is extremely appealing but services face an uphill challenge of retaining customers. As more grocers and restaurants get in the game, competition will remain fierce.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512